Bove Mauro 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed May 19, 2022
Insider Transaction Report
Form 4
Bove Mauro
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-17+240,000→ 240,000 totalExercise: $0.19Exp: 2032-05-17→ Common Stock (240,000 underlying)
Holdings
- 0
Common Stock Warrant (right to buy)
Exercise: $0.45From: 2021-04-15Exp: 2025-10-15→ Common Stock (20,880 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.36Exp: 2022-06-30→ Common Stock (100,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.64Exp: 2023-03-16→ Common Stock (100,000 underlying) - 125,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (125,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (200,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2029-05-15→ Common Stock (200,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.30Exp: 2030-06-10→ Common Stock (200,000 underlying) - 31,250
Convertible Promissory Note (right to buy)
Exercise: $0.12From: 2019-02-27Exp: 2024-02-27→ Common Stock (41,667 underlying) - 240,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2031-08-02→ Common Stock (240,000 underlying) - 31,250
Convertible Promissory Note (right to buy)
Exercise: $0.12From: 2019-05-13Exp: 2024-05-13→ Common Stock (41,667 underlying) - 20,880
Common Stock Warrant (right to buy)
Exercise: $0.18From: 2019-08-27Exp: 2024-02-27→ Common Stock (31,250 underlying) - 0
Common Stock Warrant (right to buy)
Exercise: $0.18From: 2019-11-13Exp: 2024-05-13→ Common Stock (31,250 underlying) - 0
Convertible Promissory Note (right to buy)
Exercise: $0.36From: 2020-10-15Exp: 2025-10-15→ Common Stock (27,840 underlying)
Footnotes (4)
- [F1]100% vested.
- [F2]50,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.
- [F3]60,000 shares vest on each of 8/2/21, 8/2/22, 8/2/23 and 8/2/24.
- [F4]120,000 shares vest on each of 5/17/22 and 5/17/23.